Hyundai Bioscience Co. Ltd (048410) — Free Cash Flow Generation Index
Hyundai Bioscience Co. Ltd (048410) has a Free Cash Flow Generation Index of -1.81x as of December 2024. Free cash flow of ₩-4.09 Billion represents -2% of operating cash flow (₩2.26 Billion). Explore Hyundai Bioscience Co. Ltd capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Hyundai Bioscience Co. Ltd Free Cash Flow Generation Index (2008–2024)
Historical FCF Generation Index trend for Hyundai Bioscience Co. Ltd across 8 annual periods. For the full cash flow conversion analysis, see Hyundai Bioscience Co. Ltd (048410) cash conversion ratio.
Annual Free Cash Flow Generation for Hyundai Bioscience Co. Ltd (2008–2024)
Year-by-year Free Cash Flow Generation Index for Hyundai Bioscience Co. Ltd. Check Hyundai Bioscience Co. Ltd (048410) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.04x | ₩87.48 Million | ₩2.26 Billion | ₩2.17 Billion | ▲ +101.6% |
| 2020 | -2.36x | ₩-17.70 Billion | ₩7.50 Billion | ₩25.20 Billion | ▼ -433.3% |
| 2019 | -0.44x | ₩-4.06 Billion | ₩9.18 Billion | ₩3.07 Billion | ▼ -118.3% |
| 2018 | 2.41x | ₩12.07 Billion | ₩5.01 Billion | ₩7.07 Billion | ▼ -71.3% |
| 2015 | 8.41x | ₩734.93 Million | ₩87.36 Million | ₩647.57 Million | ▲ +398.9% |
| 2014 | 1.69x | ₩2.06 Billion | ₩1.22 Billion | ₩840.18 Million | ▲ +58.0% |
| 2011 | 1.07x | ₩4.24 Billion | ₩3.97 Billion | ₩267.78 Million | ▼ -22.5% |
| 2008 | 1.38x | ₩14.29 Billion | ₩10.37 Billion | ₩3.92 Billion | — |